Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP738531.RAfXLk88m_JUtBwc_LCn8UwI4MKfmjGxkBIH-HE6MAv9M130_assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738531.RAfXLk88m_JUtBwc_LCn8UwI4MKfmjGxkBIH-HE6MAv9M130_provenance.
• assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP82433.RAcwiDkYxLZGY_ZWMTDnFCoXjho2KN8TB13A8B8amKMQc130_assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82433.RAcwiDkYxLZGY_ZWMTDnFCoXjho2KN8TB13A8B8amKMQc130_provenance.
• NP68513.RABcRvYFW-sKJG06EKmy0vzDOUABkqKRDeMWduwMFFXVM130_assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP68513.RABcRvYFW-sKJG06EKmy0vzDOUABkqKRDeMWduwMFFXVM130_provenance.
• NP419622.RAbSHGN56Cx1jrjqViSQ8YqW9cA9YSI65PolPPEvclkM0130_assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419622.RAbSHGN56Cx1jrjqViSQ8YqW9cA9YSI65PolPPEvclkM0130_provenance.
• NP62520.RAHCgDhVnuLzFjMeePm0_7hfCS-iDKdtGada6nsmTg-Vs130_assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP62520.RAHCgDhVnuLzFjMeePm0_7hfCS-iDKdtGada6nsmTg-Vs130_provenance.
• NP82432.RAgX6aFqShv3jQfEjJnrjxIlf6PqRrMeuxEbnZocy9rOo130_assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82432.RAgX6aFqShv3jQfEjJnrjxIlf6PqRrMeuxEbnZocy9rOo130_provenance.
• NP738247.RAGaEuKfq1maktWZYFAL2O_Ww2wyU2NBnXgANz14C5JbI130_assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738247.RAGaEuKfq1maktWZYFAL2O_Ww2wyU2NBnXgANz14C5JbI130_provenance.
• NP419623.RAF7u9cIH_ULu17iyViST14n76flySefJTS2eYawMjgrw130_assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419623.RAF7u9cIH_ULu17iyViST14n76flySefJTS2eYawMjgrw130_provenance.
• NP419624.RAIFc_rDykhxPIXAISQYZULsoxRdQ2h3pC0TAUzES26Yo130_assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419624.RAIFc_rDykhxPIXAISQYZULsoxRdQ2h3pC0TAUzES26Yo130_provenance.
• NP419621.RA1YJNshs_gIwY2SIwrRQOAdAma3mOw6kidYsOaQWN0as130_assertion description "[Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419621.RA1YJNshs_gIwY2SIwrRQOAdAma3mOw6kidYsOaQWN0as130_provenance.